Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010
Date:1/28/2010

DETROIT, Jan. 28 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) generated net sales of $52.0 million and $178.4 million for the third quarter and first nine months of Fiscal 2010, respectively, compared to $55.7 million and $286.2 million, respectively, during the corresponding periods of Fiscal 2009. Net sales decreased during the third quarter and first nine months of Fiscal 2010, in comparison to the corresponding periods of Fiscal 2009, primarily as a result of the adverse effect on sales of Caraco-owned products (those products for which Caraco owns the ANDAs) due to the actions of the FDA and the cessation of manufacturing, and in part due to the negative impact of our voluntary recalls. Sales of distributed products were lower during the first nine months of Fiscal 2010 over the corresponding period of Fiscal 2009 due to higher sales of Paragraph IV products during the first nine months of Fiscal 2009, particularly sales of certain Paragraph IV products which were launched by the Company during the fourth quarter of Fiscal 2008 under the distribution and sale agreement with Sun Pharma. These product sales may or may not be sustainable, as previously disclosed. The sales of distributed products were also lower due to price erosion on the products sold, partially offset by new product launches.  The Company incurred a net pre-tax loss of $4.9 million during the third quarter and $8.8 million during the first nine months of Fiscal 2010, as compared to earning net pre-tax income of $6.5 million and $33.4 m
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors
2. Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of F. Folsom Bell to Board of Directors
3. Caraco Pharmaceutical Laboratories, Ltd. Announces Reversal of Summary Judgment in Ultracet(R) ANDA Patent Litigation
4. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Imitrex(R) Tablets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent Litigation
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as Jitendra N. Doshi Assumes Position of CEO
7. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010
8. Caraco Pharmaceutical Laboratories, Ltd. Announces Filing of Purported Class Action Lawsuits
9. Forest Laboratories and H. Lundbeck A/S Enter Into Settlement Agreement With Sun and Caraco Related to LEXAPRO(R) Patent Litigation
10. Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
11. Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its Workforce
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... What makes a legend? In the case of renowned ... of exceptional courtroom performance, championing big causes and underdogs alike ... brilliant service, the Dallas Bar Association has named Schmidt a ... at a luncheon on Tuesday, April 7, 2015 at 12 ... nominees for this year are Bob Vial, Deborah Hankinson and ...
(Date:3/5/2015)... 05, 2015 Aureus Medical Group (web: ... tenens and direct hire physician jobs, has announced that ... Academy of Family Physicians 67th Annual Meeting & Scientific ... Vista, Nebraska. , The Annual Meeting & Scientific ... networking opportunities, and an exhibition of products and services. ...
(Date:3/5/2015)... Affirmed Housing is pleased to announce the ... 4 at 10AM. The event, located on Edgewood ... president, City of San Diego; James Silverwood, President & ... Southern California Community Development, Bank of American Merrill Lynch; ... Commission. , Designed to blend harmoniously with ...
(Date:3/5/2015)... Lake City,Utah (PRWEB) March 05, 2015 ... manufactures microFET medical dynamometers, ergoFET physical therapy, ... systems with sensors for ergonomics, engineering, and ... microFET Digital Handgrip Dynamometer, available at ... was designed to offer healthcare professionals a ...
(Date:3/5/2015)... Hinton, W.Va. (PRWEB) March 05, 2015 ... looming, but rather here—and it’s a crisis that is ... , In order to stay on top of ... are partnering with PracticeLink to meet face-to-face with physicians ... Career Advancement Workshop and Job Fair series. , Physician ...
Breaking Medicine News(10 mins):Health News:C.L. Mike Schmidt Named "Legend In Trial Law" by Dallas Bar Association 2Health News:Healthcare Staffing Agency, Aureus Medical Group, to Exhibit at the Nebraska Academy of Family Physicians Annual Meeting & Scientific Assembly 2Health News:SD City Council President Sherri Lightner and Affirmed Housing Break Ground on Affordable Homes in Carmel Valley 2Health News:New Handgrip Strength Tester Receives Rave Reviews At Physical Therapy Conference 2Health News:Physician Shortage Crisis Worsening 2
... Thursday November 8, 2007, at ... 8:30 AM ... NRM) reported results for the third quarter ended September 30,2007. Effective July ... currency, thus all figures reported are reported,in US dollars, unless otherwise specified. ...
... Foundation Health Plan,Inc., Kaiser Foundation Hospitals and their ... quarter ending September 30, 2007, of,$9.4 billion, as ... last year. KFHP/H,s operating income for the ... million during the same period of 2006. Ongoing ...
... Calif., Nov. 7 Nektar,Therapeutics (Nasdaq: NKTR ) ... that ended September 30, 2007. Revenue totaled $56.3 ... million in the third quarter of 2006. For the ... of $207.3 million,compared to $147.8 million in the same ...
... Nov. 7 U.S. Environmental,Protection Agency Region 5 ... Lung,Association of Indiana for a community-based initiative to ... promoting indoor air,quality and healthy schools in Fort ... "EPA is concerned about the health and welfare ...
... Medical Charity Hopes To Bring Peace and Healing with New ... Hospital in ... CURE International, a U.S.-based,Christian medical charity which operates teaching hospitals ... million,state-of-the-art medical training center and hospital in Bethlehem,Palestine. The facility ...
... fumes, volunteers, blood platelets thickened, study found , WEDNESDAY, Nov. ... formation and blood platelet activity, boosting men,s risk for heart ... The volunteers -- 20 healthy men, ages 21 to 44 ... a control) and then to diluted diesel exhaust at 300 ...
Cached Medicine News:Health News:Neurochem reports results for third quarter of fiscal 2007 2Health News:Neurochem reports results for third quarter of fiscal 2007 3Health News:Neurochem reports results for third quarter of fiscal 2007 4Health News:Neurochem reports results for third quarter of fiscal 2007 5Health News:Neurochem reports results for third quarter of fiscal 2007 6Health News:Neurochem reports results for third quarter of fiscal 2007 7Health News:Neurochem reports results for third quarter of fiscal 2007 8Health News:Neurochem reports results for third quarter of fiscal 2007 9Health News:Neurochem reports results for third quarter of fiscal 2007 10Health News:Neurochem reports results for third quarter of fiscal 2007 11Health News:Neurochem reports results for third quarter of fiscal 2007 12Health News:Neurochem reports results for third quarter of fiscal 2007 13Health News:Neurochem reports results for third quarter of fiscal 2007 14Health News:Neurochem reports results for third quarter of fiscal 2007 15Health News:Neurochem reports results for third quarter of fiscal 2007 16Health News:Neurochem reports results for third quarter of fiscal 2007 17Health News:Neurochem reports results for third quarter of fiscal 2007 18Health News:Kaiser Foundation Health Plan Earnings Support Investments in Member and Community Health 2Health News:Kaiser Foundation Health Plan Earnings Support Investments in Member and Community Health 3Health News:Kaiser Foundation Health Plan Earnings Support Investments in Member and Community Health 4Health News:Nektar Therapeutics Announces Third Quarter 2007 Financial Results 2Health News:Nektar Therapeutics Announces Third Quarter 2007 Financial Results 3Health News:Nektar Therapeutics Announces Third Quarter 2007 Financial Results 4Health News:Nektar Therapeutics Announces Third Quarter 2007 Financial Results 5Health News:Nektar Therapeutics Announces Third Quarter 2007 Financial Results 6Health News:Nektar Therapeutics Announces Third Quarter 2007 Financial Results 7Health News:EPA Awards Grant to American Lung Association of Indiana for Community Environmental Health Initiative 2Health News:CURE International Plans Hospital in Bethlehem: 2Health News:Diesel Exhaust Increases Clot Formation 2
(Date:3/4/2015)... , March 4, 2015  Vanda Pharmaceuticals ... announced top-line results of the Phase II proof ... efficacy of tradipitant as a monotherapy in the ... dermatitis. Despite a highly significant and clinically meaningful ... baseline, p<0.0001) as measured on a 100mm unit ...
(Date:3/4/2015)... BEDFORD, Mass., March 4, 2015 GSI Group ... "our", "GSI"),  a global leader and supplier of precision ... medical equipment and advanced industrial technology markets, today reported ... 2014. Unless otherwise noted, all financial results in this ... Fourth QuarterDuring the fourth quarter of 2014, ...
(Date:3/4/2015)... PARK, Calif. , March 4, 2015  Nevro ... company that has developed and commercialized an innovative, evidence-based ... announced that it will release financial results for the ... close on Wednesday, March 18, 2015. Company management will ... Time (4:30 p.m. Eastern Time) on Wednesday, March 18, ...
Breaking Medicine Technology:Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 4GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 5GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 6GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 8GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 9GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 10GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 11GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 12GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 13GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 14GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 15GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 16GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 17GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 18GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 19GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 20GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 21GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 22GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 23GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 24GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 25GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 26GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 27GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 28GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 29GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 30
... , BRIDGEWATER, N.J., Dec. 1 ... announced today that it is launching a new initiative to ... living with HIV/AIDS. Through a comprehensive campaign including local educational ... , the company is sharing learnings from the GRACE study, ...
... , NEW YORK, ... dynamics for an industry experiencing significant change, and rapidly evolving healthcare ... for the pharmaceutical and life sciences industry, according ... Taxing times ahead - Which path will you take? The ...
Cached Medicine Technology:Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 3Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 4Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 5
Multi-frequency, HST, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path. This transducer incorporates ALOKAs exclusive Hemispheric Sound Technology and ...
Multi-frequency, Super High Density, linear transducer with a longer (60mm) footprint. Available with puncture adapter and water path....
... high frequency (13Mhz) ... and superficial imaging. ... Hemispheric Sound Technology ... This multi-frequency transducer ...
This versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
Medicine Products: